News

USP News
Jornal da USP: Anvisa (National Health Surveillance Agency) ratifies the safety of CAR-T therapy and authorizes the continuation of the clinical trial
After approval, the clinical trial will be able to recruit and treat patients with B-cell acute lymphoblastic leukemia or B-cell non-Hodgkin’s lymphoma at partner centers beginning in 2025.
12 de dezembro de 2024

USP News
Jornal da USP: Media literacy educates young people to combat misinformation
This content is in Portuguese.
11 de dezembro de 2024

USP News
FMRP-USP: The Faculdade de Medicina de Ribeirão Preto inaugurates an international health research laboratory in partnership with the French CNRS
This content is in Portuguese.
9 de dezembro de 2024

USP News
Jornal da USP: HC promotes a skin cancer prevention campaign this weekend
This content is in Portuguese.
5 de dezembro de 2024

USP News
Jornal da USP: Scientists discover a new pathway for selenium incorporation into proteins
This content is in Portuguese.
29 de novembro de 2024

USP News
Jornal da USP: Scientist tests breast cancer recurrence treatment on herself
This content is in Portuguese.
28 de novembro de 2024

USP News
Jornal da USP: Hospital das Clínicas in São Paulo offers free skin cancer prevention screening
This content is in Portuguese.
27 de novembro de 2024

USP News
Jornal da USP: USP team wins Nuclear Olympiad with a project to improve access to radiotherapy in Brazil
This content is in Portuguese.
26 de novembro de 2024

USP News
Jornal da USP: Nicotine levels are up to six times higher in e-cigarette users compared to those who smoke 20 regular cigarettes a day
This content is in Portuguese.
26 de novembro de 2024

USP News
Jornal da USP: Recipes for cancer patients: e-book teaches how to enjoy meals
This content is in Portuguese.
25 de novembro de 2024

USP News
Jornal da USP: The Radiology Institute of Hospital das Clínicas celebrates 30 years as a reference in diagnostic imaging
The center of excellence linked to USP’s Faculty of Medical Sciences performs more than 1 million tests a year and is a pioneer in nuclear medicine technologies in the country.
22 de novembro de 2024